首页> 外文OA文献 >Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model

【2h】

Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model

机译：新型蛋白酶体抑制剂NPI-0052（Marizomib）在人血浆胞浆卵黄移植小鼠模型中的药效学和疗效研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ajita V. Singh; Michael A. Palladino; George Kenneth Lloyd; Barbara C. Potts; Dharminder Chauhan; Kenneth C. Anderson;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model. [J] . Singh AV, Palladino MA, Lloyd GK, British Journal of Haematology . 2010,第4期

机译：新型蛋白酶体抑制剂NPI-0052（marizomib）在人浆细胞瘤异种移植小鼠模型中的药效和功效研究。
2. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model [J] . Ajita V. Singh, Michael A. Palladino, George Kenneth Lloyd, British Journal of Haematology . 2010,第4期

机译：新型蛋白酶体抑制剂NPI-0052（marizomib）在人浆细胞瘤异种移植小鼠模型中的药效和功效研究
3. Preclinical pharmacokinetic (PK)/pharmacodynamic (PD)/Efficacy modeling for MLN2480, an investigational pan-RAF kinase inhibitor, in A375 and SKMEL-2 human melanoma xenografts [J] . Patel M., Chouitar J., Mettetal J., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2014,第Suppla6期

机译：MLN2480（一种研究性泛RAF激酶抑制剂）在A375和SKMEL-2人黑素瘤异种移植物中的临床前药代动力学（PK）/药效学（PD）/功效模型
4. Combination of angiogenesis inhibitors increases the anti-tumor efficacy of photodynamic therapy in a human bladder tumor xenograft model [C] . Ramaswamy Bhuvaneswari, Yik Yuen Gan, Patricia SP Thong, World congress of the International Photodynamic Association . 2009

机译：血管生成抑制剂的组合增加了光动力疗法在人膀胱肿瘤异种移植模型中的抗肿瘤功效
5. Clinical predictive value of pre-clinical cancer models: A study of the predictive value of the in vitro cell line, human xenograft and murine allograft pre-clinical cancer models for phase II clinical trials of cytotoxic cancer drugs [D] . Voskoglou-Nomikos, Theodora 2001

机译：临床前癌症模型的临床预测价值：体外细胞系，人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
6. Pharmacodynamic and Efficacy Studies of the Novel Proteasome Inhibitor NPI-0052 (marizomib) in a Human Plasmacytoma Xenograft Murine Model [O] . Ajita V. Singh, Michael A. Palladino, G. Kenneth Lloyd, -1

机译：的药效学和功效研究小说蛋白酶体抑制剂NpI-0052（marizomib）在人异种移植浆小鼠模型
7. Proteasome Regulator Marizomib (NPI-0052) Exhibits Prolonged Inhibition, Attenuated Efflux, and Greater Cytotoxicity than Its Reversible Analogs [O] . Obaidat, Amanda, Weiss, Jeffrey, Wahlgren, Brett, 2011

机译：蛋白酶体调节剂Marizomib（NPI-0052）比其可逆类似物具有更长的抑制作用，减弱的外排作用和更大的细胞毒性

Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model

著录项

引文网络

相似文献

相关主题

期刊订阅